View of The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study

Return to Issue Details The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study Download Download PDF